Medical Ethics achieves increased investment from Dechra Pharmaceuticals

The UK based Dechra Pharmaceuticals has announced their increased investment in Medical Ethics. Dechra has investments $13.5 million for a further 15% stake in the company. increasing its holding to 48%.

The full announcement by Dechra Pharmaceuticals can be accessed here.